Ionis Pharmaceuticals Inc

-0.34 (-0.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.45B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$139.45 Million
Adjusted EPS-$0.61
See more estimates
10-Day MA$36.90
50-Day MA$37.43
200-Day MA$34.35
See more pivots

Ionis Pharmaceuticals Inc Stock, NASDAQ:IONS

2855 Gazelle Court, Carlsbad, California 92010
United States of America
Phone: +1.760.931.9200
Number of Employees: 660


Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.